quinoxalines has been researched along with angiotensin ii in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.71) | 18.7374 |
| 1990's | 14 (50.00) | 18.2507 |
| 2000's | 9 (32.14) | 29.6817 |
| 2010's | 2 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunn, WR; McGrath, JC; Wilson, VG | 2 |
| Armstead, WM; Hyman, AL; Kadowitz, PJ; Lippton, HL | 1 |
| Shepperson, NB | 1 |
| Guyenet, PG; Li, YW | 1 |
| Faber, JE; Ikeoka, K | 1 |
| Goshima, Y; Misu, Y; Miyamae, T; Okumura, F; Sato, K | 1 |
| Bohmann, C; Rist, W; Rump, LC; Schollmeyer, P | 1 |
| Beenen, OH; Mathy, MJ; Pfaffendorf, M; van Zwieten, PA | 2 |
| Dinh, DT; Fabiani, ME; Story, DF | 1 |
| Ackermann, A; Fernández-Alfonso, MS; González, C; Ortega, T; Paul, M; Sánchez de Rojas, R | 1 |
| Kendall, DA; Roberts, RE; Tomlinson, AE; Wilson, VG | 1 |
| Cohen, RA; Griswold, MC; Komalavilas, P; Lincoln, TM; Weisbrod, RM; Yaghoubi, M | 1 |
| Brown, C; Hassid, A; Pan, X | 1 |
| Kendall, DA; Roberts, RE; Wilson, VG | 1 |
| Carlson, EJ; Drewett, JG; Kreklau, EL | 1 |
| Mayeux, PR; Zhang, C | 1 |
| Herzer, WA; Jackson, EK; Kost, CK; Vyas, SJ | 1 |
| Gao, L; Jackson, EK; Zhu, C | 2 |
| Guimarães, S; Mota, A | 1 |
| Chatterjee, S; Freedman, RR; Furspan, PB | 1 |
| O'donovan, MJ; Oz, M; Renaud, LP; Yang, KH | 1 |
| de Godoy, MA; de Oliveira, AM; Fukada, SY; Tirapelli, CR | 1 |
| Chen, J; Fan, F; Han, L; Wang, S; Wang, X; Xie, X; Yan, J; Zhou, X | 1 |
| Castillo, C; Castillo, EF; López, RM; Pérez, T | 1 |
| Chen, L; Feng, Y; Gan, H; Haydon, RC; He, TC; Huang, B; Huang, S; Lei, J; Liu, W; Luo, W; Luu, HH; Shu, Y; Wang, X; Xia, Y; Yan, S; Yu, X; Yuan, C; Zeng, L; Zeng, Z; Zhang, B; Zhang, H; Zhang, L; Zhang, R; Zhang, X; Zhao, C | 1 |
1 trial(s) available for quinoxalines and angiotensin ii
| Article | Year |
|---|---|
Increased tyrosine phosphorylation mediates the cooling-induced contraction and increased vascular reactivity of Raynaud's disease.
Topics: Adrenergic alpha-Agonists; Adult; Angiotensin II; Arterioles; Brimonidine Tartrate; Cold Temperature; Enzyme Inhibitors; Female; Genistein; Humans; Middle Aged; Phosphorylation; Protein-Tyrosine Kinases; Quinoxalines; Raynaud Disease; Serotonin; Signal Transduction; Skin; Skin Temperature; Tyrosine; Tyrphostins; Vasoconstriction; Vasoconstrictor Agents | 2004 |
27 other study(ies) available for quinoxalines and angiotensin ii
| Article | Year |
|---|---|
Postjunctional alpha-adrenoceptors in the rabbit isolated distal saphenous artery: indirect sensitivity to prazosin of responses to noradrenaline mediated via postjunctional alpha 2-adrenoceptors.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Brimonidine Tartrate; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Prazosin; Quinoxalines; Rabbits; Receptors, Adrenergic, alpha; Yohimbine | 1991 |
Influence of nisoldipine on vascular resistance and vasoconstrictor responses in cats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Azepines; Blood Pressure; Brimonidine Tartrate; Cardiac Output; Cats; Dinoprost; Dioxanes; Electric Stimulation; Female; Idazoxan; Male; Methoxamine; Nifedipine; Nisoldipine; Norepinephrine; Phenylephrine; Prostaglandin Endoperoxides, Synthetic; Prostaglandins F; Quinoxalines; Splanchnic Circulation; Sulfonamides; Sympathetic Nervous System; Tyramine; Vascular Resistance; Vasoconstriction | 1987 |
Expression of functional postjunctional alpha 2-adrenoceptors in rabbit isolated distal saphenous artery--a permissive role for angiotensin II?
Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Arteries; Brimonidine Tartrate; Drug Interactions; In Vitro Techniques; Male; Prazosin; Quinoxalines; Rabbits; Receptors, Adrenergic, alpha; Vasoconstriction; Yohimbine | 1989 |
Alpha 2-adrenoceptor agonists potentiate responses mediated by alpha 1-adrenoceptors in the cat nictitating membrane.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Brimonidine Tartrate; Cats; Clonidine; Female; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Nictitating Membrane; Norepinephrine; Phenylephrine; Quinolizines; Quinoxalines; Receptors, Adrenergic, alpha | 1984 |
Neuronal excitation by angiotensin II in the rostral ventrolateral medulla of the rat in vitro.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Biphenyl Compounds; Brimonidine Tartrate; Evoked Potentials; Imidazoles; In Vitro Techniques; Kynurenic Acid; Losartan; Medulla Oblongata; Neurons; Quinoxalines; Rats; Rats, Sprague-Dawley; Tetrazoles; Time Factors | 1995 |
ANG II reverses selective inhibition of alpha 2-adrenoceptor sensitivity after in vitro isolation of arterioles.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Arterioles; Brimonidine Tartrate; Histological Techniques; In Vitro Techniques; Phenylephrine; Prazosin; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Yohimbine | 1993 |
L-dopa potentiates presynaptic inhibitory alpha 2-adrenoceptor- but not facilitatory angiotensin II receptor-mediated modulation of noradrenaline release from rat hypothalamic slices.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Brimonidine Tartrate; Hypothalamus; In Vitro Techniques; Levodopa; Male; Norepinephrine; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Angiotensin; Synapses; Yohimbine | 1993 |
Low concentrations of angiotensin II unmask vasoconstrictory alpha 2-adrenoceptors in isolated perfused kidneys of spontaneously hypertensive rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Angiotensin II; Animals; Blood Pressure; Brimonidine Tartrate; Dioxanes; Dose-Response Relationship, Drug; Hypertension; Idazoxan; Imidazoles; Kidney; Methoxamine; Perfusion; Prazosin; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Vasoconstriction | 1995 |
Opposite influences of hypertension and diabetes mellitus on pressor responses induced by different alpha-adrenoceptor agonists and angiotensin II in pithed rats.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Azepines; Blood Glucose; Blood Pressure; Brimonidine Tartrate; Clonidine; Decerebrate State; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Hypertension; Imidazoles; Male; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1996 |
Influence of nifedipine on pressor responses induced by different alpha-adrenoceptor agonists and angiotensin II in pithed diabetic hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Blood Pressure; Brimonidine Tartrate; Calcium; Calcium Channel Blockers; Clonidine; Diabetes Mellitus, Experimental; Hypertension; Imidazoles; Nifedipine; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Streptozocin | 1996 |
Interaction of the renin-angiotensin system, bradykinin and sympathetic nerves with cholinergic transmission in the rat isolated trachea.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Brimonidine Tartrate; Epithelium; Female; Idazoxan; In Vitro Techniques; Indoles; Indomethacin; Male; Neprilysin; Nitroarginine; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Renin-Angiotensin System; Sympathetic Nervous System; Trachea | 1997 |
Modulation of angiotensin-converting enzyme by nitric oxide.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Carotid Arteries; Diethylamines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanylate Cyclase; Male; Molsidomine; Muscle, Smooth, Vascular; Nitric Oxide; Oligopeptides; Oxadiazoles; Peptidyl-Dipeptidase A; Quinoxalines; Rabbits; Rats; Rats, Sprague-Dawley | 1998 |
Alpha2-adrenoceptor-mediated contractions of the porcine isolated ear artery: evidence for a cyclic AMP-dependent and a cyclic AMP-independent mechanism.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-Agonists; Angiotensin II; Animals; Arteries; Brimonidine Tartrate; Colforsin; Cyclic AMP; Ear; In Vitro Techniques; Muscle Contraction; Muscle Relaxation; Nitroprusside; Quinoxalines; Receptors, Adrenergic, alpha-2; Swine | 1998 |
Evidence that additional mechanisms to cyclic GMP mediate the decrease in intracellular calcium and relaxation of rabbit aortic smooth muscle to nitric oxide.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-GMP Phosphodiesterases; Angiotensin II; Animals; Aorta; Calcium; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanylate Cyclase; Manganese; Muscle Relaxation; Muscle, Smooth; Nitric Oxide; Oxadiazoles; Phosphodiesterase Inhibitors; Protein Kinase C; Purinones; Quinoxalines; Rabbits; Thionucleotides; Vasoconstrictor Agents; Vasodilator Agents | 1998 |
Nitric oxide and C-type atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: relationship to microfilament dissociation and altered cell morphology.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Actin Cytoskeleton; Angiotensin II; Animals; Aorta, Thoracic; Cell Movement; Cells, Cultured; Culture Media; Cyclic AMP; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cytoskeleton; Diffusion Chambers, Culture; Guanylate Cyclase; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Myosin Heavy Chains; Natriuretic Peptide, C-Type; Nitric Oxide; Nitric Oxide Donors; Oxadiazoles; Penicillamine; Quinoxalines; Rats; Rats, Sprague-Dawley | 1999 |
A study of NPY-mediated contractions of the porcine isolated ear artery.
Topics: Adenylyl Cyclases; Adrenergic alpha-Agonists; Angiotensin II; Animals; Brimonidine Tartrate; Colforsin; Cyclic AMP; Ear, External; In Vitro Techniques; Isometric Contraction; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Neuropeptide Y; Nitroprusside; Quinoxalines; Receptors, Adrenergic, alpha-2; Receptors, Neuropeptide Y; Regional Blood Flow; Swine; Vasoconstrictor Agents; Vasodilator Agents | 1999 |
Nitric oxide inhibits human aldosteronogenesis without guanylyl cyclase stimulation.
Topics: Adrenal Cortex; Aldosterone; Angiotensin II; Animals; Cell Line; Colforsin; Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Humans; Hydroxycholesterols; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Nitroso Compounds; Oxadiazoles; PC12 Cells; Quinoxalines; Rats | 1999 |
NO/cGMP signaling modulates regulation of Na+-K+-ATPase activity by angiotensin II in rat proximal tubules.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine; Calcium; Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Intracellular Membranes; Kidney Tubules, Proximal; Male; Nitric Oxide; omega-N-Methylarginine; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; Sodium-Potassium-Exchanging ATPase; Solubility | 2001 |
Enhanced interaction between renovascular alpha(2)-adrenoceptors and angiotensin II receptors in genetic hypertension.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Antihypertensive Agents; Arginine Vasopressin; Blood Pressure; Brimonidine Tartrate; Captopril; Hypertension; Male; Methoxamine; Nephrectomy; Protein Binding; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Angiotensin; Renal Artery; Renal Circulation; Species Specificity; Vascular Resistance; Vasoconstrictor Agents | 2001 |
alpha 2-Adrenoceptors potentiate angiotensin II- and vasopressin-induced renal vasoconstriction in spontaneously hypertensive rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Angiotensin II; Animals; Blotting, Western; Brimonidine Tartrate; Capillaries; Drug Synergism; GTP-Binding Protein alpha Subunits, Gi-Go; In Vitro Techniques; Male; Pertussis Toxin; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Vasopressin; Renal Circulation; Signal Transduction; Vasoconstrictor Agents; Vasopressins | 2003 |
Influence of alpha2-autoreceptor stimulation on the facilitation by angiotensin II and bradykinin of noradrenaline release.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Alkaloids; Angiotensin II; Animals; Animals, Newborn; Autoreceptors; Benzophenanthridines; Bradykinin; Brimonidine Tartrate; Drug Synergism; Electric Stimulation; Enzyme Inhibitors; Heart; In Vitro Techniques; Norepinephrine; Phenanthridines; Protein Kinase C; Quinoxalines; Rats; Rats, Wistar | 2003 |
Mechanism of the vascular angiotensin II/alpha2-adrenoceptor interaction.
Topics: Angiotensin II; Animals; Brimonidine Tartrate; CSK Tyrosine-Protein Kinase; Isoenzymes; Kidney; Male; Phosphatidylinositol 3-Kinases; Phospholipase C beta; Protein Kinase C; Protein-Tyrosine Kinases; Quinoxalines; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha-2; src-Family Kinases; Type C Phospholipases; Vascular Resistance | 2005 |
Presynaptic angiotensin II AT1 receptors enhance inhibitory and excitatory synaptic neurotransmission to motoneurons and other ventral horn neurons in neonatal rat spinal cord.
Topics: 2-Amino-5-phosphonovalerate; Angiotensin II; Animals; Animals, Newborn; Bicuculline; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Female; GABA Antagonists; In Vitro Techniques; Laminectomy; Male; Motor Neurons; Neural Inhibition; Patch-Clamp Techniques; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Spinal Cord; Strychnine; Synaptic Transmission; Tetrodotoxin | 2005 |
Analysis of the mechanisms underlying the vasorelaxant action of angiotensin II in the isolated rat carotid.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Carotid Arteries; Dose-Response Relationship, Drug; Drug Antagonism; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Oxadiazoles; Peptide Fragments; Phenylephrine; Quinoxalines; Rats; Rats, Wistar; Saralasin; Vasoconstrictor Agents; Vasodilation | 2006 |
Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: correlated with NO-cGMP signaling pathway.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiovascular Agents; Cell Proliferation; Cell Size; Cells, Cultured; Cyclic GMP; Fibroblasts; Intracellular Space; L-Lactate Dehydrogenase; Male; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes | 2007 |
Effects induced by inhibitors of the phosphatidylinositol 3-kinase/Akt and nitric oxide synthase/guanylyl cyclase pathways on the isometric contraction in rat aorta: a comparative study.
Topics: Androstadienes; Angiotensin II; Animals; Aorta, Thoracic; Chromones; Endothelium, Vascular; Guanylate Cyclase; Isometric Contraction; Male; Morpholines; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Oxadiazoles; Phenylephrine; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Potassium; Proto-Oncogene Proteins c-akt; Quinoxalines; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Wortmannin | 2011 |
A blockade of PI3Kγ signaling effectively mitigates angiotensin II-induced renal injury and fibrosis in a mouse model.
Topics: Angiotensin II; Animals; Cell Proliferation; Class Ib Phosphatidylinositol 3-Kinase; Cytokines; Disease Models, Animal; Fibroblasts; Fibrosis; Kidney; Mice; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Quinoxalines; Renal Insufficiency, Chronic; Thiazolidinediones | 2018 |